Influence of posttransplant time on dose and concentration of tacrolimus in liver transplant patients
β Scribed by L. Pou; M. Brunet; I. Andres; M. Rodamilans; R. Lopez; J. Corbella
- Publisher
- Springer
- Year
- 1998
- Tongue
- English
- Weight
- 109 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0934-0874
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The pharmacokinetics of mycophenolate mofetil (MMF) in liver transplant recipients may change because of pharmacokinetic interactions with coadministered immunosuppressants or because changes in the enterohepatic anatomy may affect biotransformation of MMF to mycophenolic acid (MPA) and enterohepati
Epstein-Barr virus (EBV)-associated posttransplant lymphoproliferative disorder (PTLD) is a life-threatening complication after adult orthotopic liver transplantation (AOLT). Besides EBV and immunosuppression, relatively little is known about the pretransplant clinical parameters associated with the